NSAID-INDUCED POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS
Open Access
- 22 June 1996
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 25 (2), 349-361
- https://doi.org/10.1016/s0889-8553(05)70251-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Sulindac has maximal effect on small but not large polyps in the duodenum in patients with familial adenomatous polyposisGastroenterology, 1995
- NSAIDs inhibit the growth of colon cancer cell lines by a prostaglandin independent pathway:Gastroenterology, 1995
- The sulfone metabolite of sulindac (FGN-1) inhibits rat colonic carcinogenesis but does not inhibit either prostaglandin synthesis or colonic proliferation:Gastroenterology, 1995
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994
- Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous PolyposisNew England Journal of Medicine, 1993
- Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemopreventionJournal of Cellular Biochemistry, 1992
- Sulindac causes regression of rectal polyps in familial adenomatous polyposisGastroenterology, 1991
- Identification of FAP Locus Genes from Chromosome 5q21Science, 1991
- Nonsteroidal Antiinflammatory Drugs — Differences and SimilaritiesNew England Journal of Medicine, 1991
- SULINDAC TREATMENT FOR FAMILIAL POLYPOSIS COLIThe Lancet, 1985